Grant: Engage Grants Program
McMaster University
$25,000.00
Assay for thyroid hormone diagnostics by direct injection-tandem mass spectrometry
EF 2013-14
Résumé
This project aims to develop a simple, selective yet ultra-sensitive assay to measure thyroid hormones in human blood by electrospray ionization-tandem mass spectrometry (ESI-MS/MS) in partnership with a local Canadian instrument manufacturer, Ionics Mass Spectrometry. Thyroid hormone status is widely measured in clinical laboratories in the context of newborn screening, as well as diagnostic testing and treatment monitoring of various acquired thyroid related-diseases (e.g., hypothyroidism) that impact human health and quality of life. Currently, thyroid hormones are measured by fluorescence-based immunoassays that lack adequate selectivity resulting in bias and high rates of false-positives. There is an urgent need for alternative methods that offer improved reliability and lower operating costs for routine testing of thyroid function in a clinical setting. However, due to its extremely low concentration levels and inherent instability, direct analysis of thyroid hormones by ESI-MS/MS is challenging due to plasma interferences that result in ion suppression. We propose to introduce an improved strategy for free and/or protein-bound thyroid hormone analysis based on a novel sample cleanup and sensitivity enhancement protocol prior to direct injection-ESI-MS/MS. Method optimization will take place in our laboratory at McMaster University followed by its translation at Ionics Mass Spectrometry for subsequent validation. This timely project will provide a rapid yet cost-effective clinical application of MS/MS technology for routine diagnostic testing of thyroxine hormone status without low throughput chromatographic separations that will improve patient care based on early detection of treatable thyroid related-disorders.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
451879-2013
Name nom
BritzMcKibbin, Philip
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Assay for thyroid hormone diagnostics by direct injection-tandem mass spectrometry
Keyword
NSERC
Application summary
This project aims to develop a simple, selective yet ultra-sensitive assay to measure thyroid hormones in human blood by electrospray ionization-tandem mass spectrometry (ESI-MS/MS) in partnership with a local Canadian instrument manufacturer, Ionics Mass Spectrometry. Thyroid hormone status is widely measured in clinical laboratories in the context of newborn screening, as well as diagnostic testing and treatment monitoring of various acquired thyroid related-diseases (e.g., hypothyroidism) that impact human health and quality of life. Currently, thyroid hormones are measured by fluorescence-based immunoassays that lack adequate selectivity resulting in bias and high rates of false-positives. There is an urgent need for alternative methods that offer improved reliability and lower operating costs for routine testing of thyroid function in a clinical setting. However, due to its extremely low concentration levels and inherent instability, direct analysis of thyroid hormones by ESI-MS/MS is challenging due to plasma interferences that result in ion suppression. We propose to introduce an improved strategy for free and/or protein-bound thyroid hormone analysis based on a novel sample cleanup and sensitivity enhancement protocol prior to direct injection-ESI-MS/MS. Method optimization will take place in our laboratory at McMaster University followed by its translation at Ionics Mass Spectrometry for subsequent validation. This timely project will provide a rapid yet cost-effective clinical application of MS/MS technology for routine diagnostic testing of thyroxine hormone status without low throughput chromatographic separations that will improve patient care based on early detection of treatable thyroid related-disorders.